(CWK) Cushman & Wakefield - Overview
Stock: Facilities Management, Leasing, Valuation, Capital Markets, Advisory
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 41.1% |
| Relative Tail Risk | -8.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 0.46 |
| Character TTM | |
|---|---|
| Beta | 1.266 |
| Beta Downside | 1.420 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.43% |
| CAGR/Max DD | 0.07 |
Description: CWK Cushman & Wakefield January 12, 2026
Cushman & Wakefield plc (NYSE:CWK) delivers a full suite of commercial real-estate services worldwide, spanning integrated facilities management, project development, portfolio administration, transaction and strategic consulting, as well as property-management, sustainability, and tenant-experience solutions. The firm also offers owner- and tenant-representation leasing, capital-market services (investment sales, equity, debt and structured financing), and a broad set of valuation, advisory, and litigation-support offerings for real-estate owners, occupiers, investors and multinational corporations.
Key operating metrics that illustrate the company’s recent performance include FY 2023 revenue of roughly **$9.7 billion**, an adjusted EBITDA margin of **~13 %**, and a **5 % year-over-year increase** in facilities-management contracts, driven by heightened demand for outsourced workplace services. The sector is currently being shaped by three macro drivers: (1) a tightening of global credit conditions that pressures real-estate financing, (2) a shift toward flexible-office and ESG-focused space that boosts demand for sustainability and tenant-experience services, and (3) slowing office-space absorption in major metros, which is prompting owners to outsource asset-level management to firms like CWK.
For a deeper quantitative view, you might explore ValueRay’s platform for real-time CWK metrics and comparable peer analysis.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 223.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: 1.66% < 20% (prev 4.35%; Δ -2.70% < -1%) |
| CFO/TA 0.03 > 3% & CFO 198.3m > Net Income 223.5m |
| Net Debt (2.48b) to EBITDA (569.2m): 4.35 < 3 |
| Current Ratio: 1.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (235.9m) vs 12m ago 1.07% < -2% |
| Gross Margin: 17.81% > 18% (prev 0.18%; Δ 1763 % > 0.5%) |
| Asset Turnover: 131.4% > 50% (prev 124.4%; Δ 7.05% > 0%) |
| Interest Coverage Ratio: 2.12 > 6 (EBITDA TTM 569.2m / Interest Expense TTM 217.0m) |
Altman Z'' -0.02
| A: 0.02 (Total Current Assets 2.67b - Total Current Liabilities 2.51b) / Total Assets 7.69b |
| B: -0.11 (Retained Earnings -875.3m / Total Assets 7.69b) |
| C: 0.06 (EBIT TTM 460.9m / Avg Total Assets 7.61b) |
| D: -0.19 (Book Value of Equity -1.06b / Total Liabilities 5.73b) |
| Altman-Z'' Score: -0.02 = B |
Beneish M -2.89
| DSRI: 1.08 (Receivables 1.83b/1.58b, Revenue 10.00b/9.37b) |
| GMI: 1.00 (GM 17.81% / 17.89%) |
| AQI: 1.02 (AQ_t 0.60 / AQ_t-1 0.59) |
| SGI: 1.07 (Revenue 10.00b / 9.37b) |
| TATA: 0.00 (NI 223.5m - CFO 198.3m) / TA 7.69b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of CWK shares?
Over the past week, the price has changed by -1.70%, over one month by -3.00%, over three months by +4.80% and over the past year by +21.50%.
Is CWK a buy, sell or hold?
- StrongBuy: 1
- Buy: 3
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CWK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.4 | 13.9% |
| Analysts Target Price | 18.4 | 13.9% |
| ValueRay Target Price | 16.5 | 2% |
CWK Fundamental Data Overview February 03, 2026
P/E Forward = 13.7174
P/S = 0.3806
P/B = 1.9676
P/EG = 0.6181
Revenue TTM = 10.00b USD
EBIT TTM = 460.9m USD
EBITDA TTM = 569.2m USD
Long Term Debt = 2.72b USD (from longTermDebt, last quarter)
Short Term Debt = 129.2m USD (from shortTermDebt, last quarter)
Debt = 3.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.48b USD (from netDebt column, last quarter)
Enterprise Value = 6.28b USD (3.81b + Debt 3.11b - CCE 634.4m)
Interest Coverage Ratio = 2.12 (Ebit TTM 460.9m / Interest Expense TTM 217.0m)
EV/FCF = 35.20x (Enterprise Value 6.28b / FCF TTM 178.5m)
FCF Yield = 2.84% (FCF TTM 178.5m / Enterprise Value 6.28b)
FCF Margin = 1.78% (FCF TTM 178.5m / Revenue TTM 10.00b)
Net Margin = 2.23% (Net Income TTM 223.5m / Revenue TTM 10.00b)
Gross Margin = 17.81% ((Revenue TTM 10.00b - Cost of Revenue TTM 8.22b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 17.76%)
Tobins Q-Ratio = 0.82 (Enterprise Value 6.28b / Total Assets 7.69b)
Interest Expense / Debt = 1.80% (Interest Expense 56.0m / Debt 3.11b)
Taxrate = 25.31% (44.5m / 175.8m)
NOPAT = 344.2m (EBIT 460.9m * (1 - 25.31%))
Current Ratio = 1.07 (Total Current Assets 2.67b / Total Current Liabilities 2.51b)
Debt / Equity = 1.59 (Debt 3.11b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 4.35 (Net Debt 2.48b / EBITDA 569.2m)
Debt / FCF = 13.87 (Net Debt 2.48b / FCF TTM 178.5m)
Total Stockholder Equity = 1.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.94% (Net Income 223.5m / Total Assets 7.69b)
RoE = 12.09% (Net Income TTM 223.5m / Total Stockholder Equity 1.85b)
RoCE = 10.09% (EBIT 460.9m / Capital Employed (Equity 1.85b + L.T.Debt 2.72b))
RoIC = 7.13% (NOPAT 344.2m / Invested Capital 4.82b)
WACC = 6.43% (E(3.81b)/V(6.92b) * Re(10.58%) + D(3.11b)/V(6.92b) * Rd(1.80%) * (1-Tc(0.25)))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.52%
[DCF Debug] Terminal Value 79.03% ; FCFF base≈206.0m ; Y1≈143.4m ; Y5≈73.6m
Fair Price DCF = N/A (negative equity: EV 1.99b - Net Debt 2.48b = -485.6m; debt exceeds intrinsic value)
EPS Correlation: -42.72 | EPS CAGR: -31.58% | SUE: -4.0 | # QB: 0
Revenue Correlation: -24.71 | Revenue CAGR: -2.67% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=1.45 | Chg30d=-0.001 | Revisions Net=+1 | Growth EPS=+19.2% | Growth Revenue=+6.0%